Raymond James Financial Services Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$457K Buy
12,289
+9
+0.1% +$336 ﹤0.01% 2686
2024
Q2
$585K Buy
12,280
+43
+0.4% +$1.88K ﹤0.01% 2420
2024
Q1
$468K Hold
12,237
﹤0.01% 2570
2023
Q4
$382K Sell
12,237
-137
-1% -$4.92K ﹤0.01% 2580
2023
Q3
$497K Sell
12,374
-73
-0.6% -$3.42K ﹤0.01% 2336
2023
Q2
$654K Buy
12,447
+9
+0.1% +$548 ﹤0.01% 2183
2023
Q1
$795K Sell
12,438
-13,735
-52% -$896K ﹤0.01% 2052
2022
Q4
$1.27M Sell
26,173
-8,870
-25% -$556K ﹤0.01% 1690
2022
Q3
$2.47M Sell
35,043
-26
-0.1% -$2.23K 0.01% 1312
2022
Q2
$2.49M Hold
35,069
0.01% 1325
2022
Q1
$2.8M Buy
35,069
+45
+0.1% +$3.35K 0.01% 1309
2021
Q4
$3.2M Sell
35,024
-389
-1% -$41.7K 0.01% 1251
2021
Q3
$4.55M Buy
35,413
+219
+0.6% +$30.6K 0.01% 1033
2021
Q2
$5.37M Buy
35,194
+246
+0.7% +$32.4K 0.01% 941
2021
Q1
$3.68M Sell
34,948
-4,489
-11% -$449K 0.01% 1062
2020
Q4
$3.12M Sell
39,437
-12,354
-24% -$904K 0.01% 1051
2020
Q3
$2.93M Sell
51,791
-18,180
-26% -$979K 0.01% 988
2020
Q2
$4.31M Buy
69,971
+303
+0.4% +$12.4K 0.01% 768
2020
Q1
$2.25M Sell
69,668
-5,776
-8% -$195K 0.01% 836
2019
Q4
$2.65M Buy
75,444
+25
+0% +$825 0.01% 1030
2019
Q3
$1.94M Hold
75,419
0.01% 1124
2019
Q2
$2.22M Sell
75,419
-1,466
-2% -$42.3K 0.01% 1050
2019
Q1
$2.63M Sell
76,885
-50
-0.1% -$1.77K 0.01% 937
2018
Q4
$2.46M Sell
76,935
-62
-0.1% -$2.42K 0.01% 798
2018
Q3
$3.7M Sell
76,997
-763
-1% -$31.2K 0.02% 769
2018
Q2
$2.41M Buy
77,760
+11,648
+18% +$273K 0.01% 919
2018
Q1
$978K Buy
66,112
+5,776
+10% +$90.2K 0.01% 1313
2017
Q4
$935K Buy
60,336
+26,443
+78% +$393K 0.01% 1345
2017
Q3
$422K Buy
33,893
+14,119
+71% +$157K ﹤0.01% 1816
2017
Q2
$214K Buy
+19,774
New +$193K ﹤0.01% 2184

Other funds holding STAA

Raymond James Financial Services Advisors's STAA Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its STAAR Surgical (STAA) stake by 0.07% in Q3 2024, buying an estimated $336 and bringing the position to 12,289 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #2686.

Raymond James Financial Services Advisors first reported a position in STAA in Q2 2017 and has held it in 30 quarters since. The position peaked at $5.37M in Q2 2021. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

  • Raymond James Financial Services Advisors held 12,289 shares of STAAR Surgical worth $457K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 9 STAAR Surgical shares in Q3 2024, an estimated $336.
  • STAAR Surgical made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2686 holding.
  • Raymond James Financial Services Advisors first reported a position in STAAR Surgical in Q2 2017 and has held it in 30 quarters since.
  • Raymond James Financial Services Advisors's STAAR Surgical position peaked at $5.37M in Q2 2021.
  • 236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.